CM Life Sciences III registered today with the SEC to offer 40 million units at $10 each. This is the second SPAC in two days launched by CEO Eli Casdin, founder of Casdin Capital, an investment firm focused on the life sciences and healthcare industry.
The SPAC intends to list on the Nasdaq under CMLTU. Read more.
